Final results of Australasian Gastrointestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidines-Reference-Cited by-同舟云学术

Final results of Australasian Gastrointestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidines

Published:2014-01 Issue:1 Volume:25 Page:117-121
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Ransom D.,Wilson K.,Fournier M.,Simes R.J.,Gebski V.,Yip D.,Tebbutt N.,Karapetis C.S.,Ferry D.,Gordon S.,Price T.J.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/25/1/117/393438/mdt479.pdf

Reference24 articles.

1. Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study;Kosmas;J Cancer Res Clin Oncol,2008

2. Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine;Jensen;Cancer Chemother Pharmacol,2006

3. Bolus 5-fluorouracil as an alternative modality to infusion 5-fluorouracil in a patient with rectal cancer and capecitabine-induced cardiotoxicity;Shaib;In Vivo,2009

4. Cardiac toxicity associated with capecitabine therapy;Saif;Acta Oncol,2003

5. Fluorouracil induces myocardial ischemia with increases of plasma brain natriuretic peptide and lactic acid but without dysfunction of left ventricle;Jensen;J Clin Oncol,2010

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Irinotecan plus raltitrexed as second-line treatment in locally advanced or metastatic colorectal cancer patients: a prospective open-label, single-arm, multi-center, phase II study;BMC Cancer;2024-09-02

2. Natural killer cell-derived exosome-based cancer therapy: from biological roles to clinical significance and implications;Molecular Cancer;2024-06-29

3. Irinotecan plus raltitrexed as second‑line chemotherapy for metastatic colorectal cancer: A retrospective study;Oncology Letters;2024-06-28

4. Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study);Acta Oncologica;2024-05-02

5. Raltitrexed induces apoptosis through activating ROS-mediated ER stress by impeding HSPA8 expression in prostate cancer cells;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-03